Already have an account?


Login with an existing Projects In Knowledge account Log in with your MPT account
New to Projects In Knowledge?


Register today to customize your experience.
Log In
Don't have an account yet? Click here to register



Register for Free
Already have an account? Click here to log in



Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.



Forgot Password

Please Enter your email address.




  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy
www.projectsinknowledge.com is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of projectsinknowledge.com is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

Listserves
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact privacy@projectsinknowledge.com.

Revision date: This policy was last updated on September 30, 2003.



New and Noteworthy
Education Initiative in Neurology

  • Multiple Sclerosis — The Role of MRI in Assessing New Treatments for Secondary and Primary Progressive Multiple Sclerosis – MedImage Case
  • Dr. Christine J. Azevedo discusses secondary-progressive and primary-progressive MS, through the utilization of MRI methodology (lesion status, atrophy measures, and disease progression) along with clinical features (clinical attacks) to determine optimal treatment selection. She also addresses current ... more >>
    C. Azevedo, MD, MPH
  • Stroke Prevention — Is 'As Needed' NOAC Safe for Select Afib Patients? – Meeting Coverage
  • MedPage Today journal insight
  • Parkinson's Disease — Chapter 1.1: Epidemiology of Parkinson's Disease – @Point of Care Chapter
  • From 2005 to 2030, the number of patients with Parkinson’s disease is expected to double. Caroline M. Tanner, MD, PhD provides an overview of the epidemiology of Parkinson’s disease and its associated morbidity.
    C. Tanner, MD, Phd
  • Parkinson's Disease — Chapter 2.1: Parkinson’s Disease: Etiology and Pathophysiology – @Point of Care Chapter
  • Advances in neurobiology research in recent years have yielded a wealth of information on etiology and pathophysiology of Parkinson’s disease (PD). In addition, we have gained greater insights into the physiologic basis of neuronal degeneration in PD. This host of new knowledge now provides clinicians with a ... more >>
    M. Lew, MD, FAAN
  • Parkinson's Disease — Chapter 3.1: Screening, Diagnosis, and Prognosis – @Point of Care Chapter
  • Diagnosis of Parkinson’s disease (PD) has historically been a difficult task, as the early symptoms may be quite mild and nonspecific. Nevertheless, recent developments in biomarkers and tests offer greater opportunities for early diagnosis and early intervention. In this subchapter, Dr. Mark Lew will explore ... more >>
    M. Lew, MD, FAAN
  • Parkinson's Disease — Chapter 4.1: Management of Early-Stage Parkinson’s Disease – @Point of Care Chapter
  • The lack of a “one-size-fits-all” approach presents a significant challenge in selecting initial treatment in early Parkinson’s disease (PD). A number of effective treatments are available that provide different advantages and limitations, and deciding which agent to use first-line requires an individualized ... more >>
    R. Hauser, MD, MBA
  • Parkinson's Disease — Chapter 4.2: Management of Moderate- to Advanced-Stage Parkinson’s Disease – @Point of Care Chapter
  • Despite the benefits of standard monotherapies for early Parkinson’s disease (PD), most patients eventually develop progressive motor symptoms and complications related to levodopa therapy. Managing the motor symptoms of moderate to advanced PD becomes increasingly challenging, especially once motor ... more >>
    D. Kremens, MD, JD
  • Parkinson's Disease — Chapter 4.3: Management of Nonmotor Symptoms of Parkinson’s Disease – @Point of Care Chapter
  • Nonmotor symptoms contribute significantly to the disability associated with Parkinson’s disease (PD), but often go unrecognized and untreated. This subchapter reviews assessment tools specifically developed to identify and quantify nonmotor symptoms in PD and addresses various nonpharmacologic and ... more >>
    D. Kremens, MD, JD
  • Parkinson's Disease — Chapter 4.4: MAO-B Inhibitors in Parkinson's Disease: Evaluating the Evidence for Neuroprotection – @Point of Care Chapter
  • Do monoamine oxidase type B (MAO-B) inhibitors modify the course of early Parkinson’s disease (PD)? Has the in vitro and preclinical evidence of neuroprotective activity for this class of drugs been borne out in clinical trials? These questions have been debated for at least 2 decades, and as yet, there is no ... more >>
    R. Hauser, MD, MBA
  • Parkinson's Disease — Chapter 4.5: Novel Therapies, Evolving Strategies – @Point of Care Chapter
  • Emerging therapies to address important unmet needs in patients with Parkinson’s disease are progressing through clinical trials. Join Robert A. Hauser, MD, as he provides an overview of mechanisms of action, efficacy, and safety of emerging antiparkinsonian, antidyskinetic, and neuroprotective therapies.
    R. Hauser, MD, MBA
  • Clinical Context: Stroke Prevention in Atrial Fibrilation
  • Clinical Context: Stroke Prevention in
    Atrial Fibrillation
    is designed to provide up-to-date information on patient identification, risk factors, and current and emerging treatments and best practices in the management of atrial fibrillation.

    The curriculum includes:
    • 6 case studies
    • MedPage Today meeting
    ...
    more >>
    C. Yancy, MD, MSc
  • Clinical Context: Multiple Sclerosis

  • Clinical Context: Multiple Sclerosis is designed to provide up-to-date information on patient identification, symptoms, risk factors, and current and emerging treatments and best practices in the management of multiple sclerosis.

    The curriculum includes four case studies at the point of care and MedPage ...
    more >>
    P. Coyle, MD
  • Multiple Sclerosis: The Advanced Curriculum VII
  • Ongoing research in the field of multiple sclerosis (MS) has generated new insights into the pathophysiology, diagnosis, treatment, and management of this challenging disease. A wide array of new MRI technologies, new treatment strategies, and a better understanding of the need for early diagnosis and ... more >>
    F. Lublin, MD
    A. Miller, MD
  • Multiple Sclerosis: The Advanced Curriculum VI
  • Ongoing research in the field of multiple sclerosis (MS) has generated new insights into the pathophysiology, diagnosis, treatment, and management of this challenging disease. A wide array of new MRI technologies, new treatment strategies, and a better understanding of the need for early diagnosis and ... more >>
    F. Lublin, MD
    A. Miller, MD
  • Stroke Prevention in Atrial Fibrillation: The Advanced Curriculum
  • Atrial fibrillation (AF) is the most common form of arrhythmia and one of the leading causes of thromboembolic stroke. Because its prevalence increases with age, it is estimated that more than 6 million individuals will be affected with AF by 2050. It is critical that cardiologists and other clinicians are ... more >>
    S. Connolly, MD, FRCPC
  • Case-based Practice Improvement Video Vignette Collection: Multiple Sclerosis Edition
  • Case-Based Practice Improvement Video Vignette Collection: Multiple Sclerosis Edition, is an engaging series of CME/CE-accredited video discussions of compelling real-world patient cases, prepared and presented by renowned specialty experts.
    P. Coyle, MD
  • Parkinson's Disease Clinical Case Vignettes
  • Case-Based Practice Improvement Video Vignette Collection: Parkinson's Disease Edition, is an engaging series of CME/CE-accredited video discussions of compelling real-world patient cases, prepared and presented by renowned specialty experts.
    R. Hauser, MD, MBA
  • Multiple Sclerosis: The Advanced Curriculum V
  • Ongoing research in the field of multiple sclerosis (MS) has generated new insights into the pathophysiology, diagnosis, treatment, and management of this challenging disease. A wide array of new MRI technologies, new treatment strategies, and a better understanding of the need for early diagnosis and ... more >>
    F. Lublin, MD
    A. Miller, MD
  • Virtual Grand Rounds in Multiple Sclerosis
  • Recent advances in understanding the pathophysiology of multiple sclerosis (MS) have made possible the development of exciting new treatment options. This nine-part virtual grand rounds series explores a number of important issues, illustrated by patient examples encountered in daily practice. Covered ... more >>
    J. Bowen, MD
  • The Advanced Certificate Program in Multiple Sclerosis Management IV
  • Ongoing research in the field of multiple sclerosis (MS) has generated new insights into the pathophysiology, diagnosis, treatment, and management of this challenging disease. A wide array of new MRI technologies, new treatment strategies, and a better understanding of the need for early diagnosis and ... more >>
    F. Lublin, MD
    A. Miller, MD
  • MIC - Parkinson's Disease
  • MedImage CasesTM, a new eTextbook, is a series of biweekly MRI case presentations, providing audio commentary from renowned Parkinson's Disease experts of imaging both conventional and non-conventional form to be used as a tool to measure disease activity, disease progression, and response to therapy, and ... more >>
    R. Hauser, MD, MBA
  • Parkinson's Disease @Point of Care
  • From 2005 to 2030, the number of patients with Parkinson’s disease is expected to double. Caroline M. Tanner, MD, PhD provides an overview of the epidemiology of Parkinson’s disease and its associated morbidity in this subchapter of the Parkinson’s Disease @POC program.
    R. Hauser, MD, MBA
  • Multiple Sclerosis @Point of Care
  • MS @Point of Care is a clinical decision support platform that provides comprehensive information on the diagnosis, treatment and management of multiple sclerosis, made up of a progressive series of chapters and other learning tools. It provides multimedia offerings, and contextual expansion of content ... more >>
    B. Cohen, MD
    P. Coyle, MD
  • Parkinson's Disease Edition: Early Diagnosis and Comprehensive Management
  • Parkinson's disease is traditionally diagnosed clinically based on classic motor symptoms of tremor, rigidity, bradykinesia, and postural instability. However, it is increasingly recognized that motor symptoms are only one manifestation of this chronic neurodegenerative disease—and a late manifestation at ... more >>
    R. Hauser, MD, MBA
  • Multiple Sclerosis Edition
  • This free, interactive CME/CE textbook provides comprehensive coverage of important MS-related topics, supplemented by hyperlinks to external multimedia resources such as illustrations, videos, journal articles, and other resources, that enhance understanding of relevant issues.
    B. Cohen, MD
  • Multiple Sclerosis — Improving the Management of Walking Impairment and Foot Drop in MS – Webcast
  • Almost two-thirds of MS patients report significant difficulty in walking. Yet, approximately 40% of patients with MS rarely or never discuss this problem with their physicians. As a result of this gap in communication, many MS patients do not experience the benefits of available pharmacologic and ... more >>
    A. Goodman, MD
  • Multiple Sclerosis — How Can We Better Manage MS Patients Today? – Webcast
  • As in the case of other chronic diseases for which treatment slows disease progression but does not provide a cure, maintaining treatment adherence over the long term is a challenge for patients with MS and their physicians. Determining treatment with both clinical outcomes and adherence in mind is ... more >>
    D. Goodin, MD
  • Multiple Sclerosis — Social Media, Multiple Sclerosis, and the Neurologist – Webcast
  • Social media, Internet technologies that facilitate interaction between people, are changing how physicians interact with patients and colleagues and how patients share information with each other. Are you perplexed about what role social media should play in your practice? Dr. Andrew N. Wilner offers a guide ... more >>
    J. Ratchford, MD
  • Multiple Sclerosis — A Practical Guide to the Management and Treatment of Symptoms of Multiple Sclerosis – Webcast
  • Patients with MS are plagued by a variety of symptoms -€“ including cognitive dysfunction, depression, neuropathic pain, fatigue, spasticity, bladder and sexual dysfunction, and walking/mobility issues - that seriously impair their quality of life. Disease-modifying treatments for MS itself, as well as the ... more >>
    R. Lipsy, PharmD, BCPS, FASHP
  • Multiple Sclerosis — Symptom Management in Multiple Sclerosis – Webcast
  • For patients with multiple sclerosis (MS), maintaining quality of life is an important consideration. Join two experts in the field of MS symptom management as they discuss symptom assessment and nonpharmaceutical and pharmaceutical strategies for managing MS symptoms that particularly impact quality of life, ... more >>
    A. Ben-Zacharia, DrNP, MSCN
    A. Perrin Ross, MSN
  • Multiple Sclerosis — Recognizing and Treating Multiple Sclerosis in the Primary Care Setting-Case Study – Interactive Case Study
  • Recognizing clinically isolated syndrome (CIS) and differentiating it from clinically definite multiple sclerosis poses several challenges for primary care physicians. Once a diagnosis has been made, the clinician must then decide whether or not to treat the patient and, if so, with what. The practical issues ... more >>
    K. Kennedy, MN, ARNP
  • Multiple Sclerosis — Expert Insight Into: The Relation Between Inflammation and Neurodegeneration in Multiple Sclerosis Brains – Article Review
  • Dr. Suhayl Dhib-Jalbut reviews a study that analyzed the interdependence of inflammation, neurodegeneration, and disease progression in various multiple sclerosis stages in relation to lesional activity and clinical course, with a particular focus on progressive multiple sclerosis.
    S. Dhib-Jalbut, MD
  • Multiple Sclerosis — Recognizing and Treating Multiple Sclerosis in the Primary Care Setting – Podcast Series
  • This CME/CE on-demand audio podcast features presentations from a recent live lecture and workshop, held in Seattle, WA, that focused on the management of multiple sclerosis (MS) in the primary care setting. Join Kate E. Kennedy, MN, ARNP, and Sylvia M. Lucas, MD, PhD, who have particular expertise in caring ... more >>
    K. Kennedy, MN, ARNP
    S. Lucas, MD, PhD
  • Multiple Sclerosis — Multiple Sclerosis Resource Network - Professional Social Network and Resource for Clinicians – Web Forum
  • The MS Resource Network serves as home to an interactive MS regional community that allows you to communicate with your local peers. Use the Members and Forum links, email function, or join a Group to connect with other clinicians and participate in MS-related discussions. The more you participate and ... more >>
  • Multiple Sclerosis — A Sea Change in MS Treatment -€” The Potential of Small Molecules – Webcast
  • Recent advances in understanding the pathogenesis of multiple sclerosis and its relation to treatment, the importance of early intervention, and the use of novel small-molecule therapies are resulting in expanded treatment options and new hope for patients with this debilitating disease. Please join a panel ... more >>
    B. Cohen, MD
  • Multiple Sclerosis — The Role of MRI in Assessing New Treatments for Secondary and Primary Progressive Multiple Sclerosis – MedImage Case
  • Dr. Christine J. Azevedo discusses secondary-progressive and primary-progressive MS, through the utilization of MRI methodology (lesion status, atrophy measures, and disease progression) along with clinical features (clinical attacks) to determine optimal treatment selection. She also addresses current ... more >>
    C. Azevedo, MD, MPH
  • Stroke Prevention — Case Study: Patient with Holiday Heart Syndrome – Case Study
  • This case study in the Clinical Context: Stroke Prevention in Atrial Fibrillation program follows a 51-year-old man with atrial fibrillation that can be attributed to alcohol abuse and/or endurance athletic activity. Whether or not anticoagulation for stroke prevention is indicated is the focus of this ... more >>
    C. Yancy, MD, MSc
  • Multiple Sclerosis — Case Study: Primary Progressive Multiple Sclerosis: Patient with Reduced Endurance and Ongoing Deterioration – Case Study
  • While there have been many advances in treatments for patients with relapsing-remitting multiple sclerosis, the development of effective disease-modifying treatments for primary-progressive multiple sclerosis (PPMS) has been more challenging. This case illustrates the real-life scenario of a middle-aged man ... more >>
    P. Coyle, MD
  • Stroke Prevention — Case Study: Patient with Established Atrial Fibrillation – Case Study
  • This case study in the Clinical Context: Stroke Prevention in Atrial Fibrillation program follows an 81-year-old, overweight diabetic male with a remote history of prior myocardial infarction and coronary artery bypass graft with known atrial fibrillation deemed to be “permanent.” He is currently on warfarin ... more >>
    C. Yancy, MD, MSc
  • Stroke Prevention — Stroke Prevention in AF: Defining the Low-Risk Patient – Case Study
  • The decision to prescribe oral anticoagulant therapy for stroke prevention in atrial fibrillation (AF) is driven by the underlying estimated risk of stroke if untreated as well as the risk of bleeding on treatment. While anticoagulation is indicated in patients at high risk, the variable risk in patients at ... more >>
    C. Yancy, MD, MSc
  • Stroke Prevention — Heart Failure Patient with Atrial Fibrillation, Not Previously Treated – Case Study
  • Since patients with atrial fibrillation face a significant increase in the risk of stroke, determining stroke prophylaxis and identifying patients requiring therapy is a high priority. In this case study, Dr. Yancy discusses the risk factors for stroke in patients with heart failure and atrial fibrillation, ... more >>
    C. Yancy, MD, MSc
  • Stroke Prevention — Patient with New Onset Atrial Fibrillation – Case Study
  • Atrial fibrillation substantially increases the risk of stroke; thus, stroke prevention is a priority in all patients with atrial fibrillation. However, not all patients may need anticoagulation therapy. In this case of a patient with only one symptomatic episode of atrial fibrillation spontaneously ... more >>
    C. Yancy, MD, MSc
  • Multiple Sclerosis — Case Study #4: Treatment Decisions at Diagnosis and Breakthrough for Male Patients with Relapsing-Remitting MS Who Desire to Have Children – Case Study
  • This case study highlights two issues that clinicians who care for patients with multiple sclerosis (MS) routinely address: breakthrough disease and reproductive concerns. Join Anne H. Cross, MD, as she models making treatment decisions for a male MS patient, a 40-year-old father who desires to have more ... more >>
    A. Cross, MD
  • Multiple Sclerosis — Case Study #3: Management of Patients with Relapsing-Remitting MS and Worsening Disease on Interferon-Beta Therapy – Case Study
  • A patient with relapsing-remitting multiple sclerosis presenting with worsening disease while on a first disease-modifying therapy is not an uncommon scenario for the practicing neurologist. This scenario, however, raises complex and critical questions. How to evaluate relapse? How to choose a personalized ... more >>
    S. Krieger, MD
  • Multiple Sclerosis — Case Study #2: Management of Multiple Sclerosis Patients Who Are Positive for the Anti-JC Virus Antibody – Case Study
  • Navigating the multiple sclerosis disease-modifying therapy options for patients who need to switch therapy due to the development of more active disease, particularly for patients who are positive for anti-JC virus antibody, is a common challenge for clinicians. Join Patricia K. Coyle, MD, for this case ... more >>
    P. Coyle, MD